Supplement: Brenda Gavin

Brenda Gavin By Karen Pallarito The making of a venture capitalist. RELATED ARTICLES A Region Defined Did You Know? A Rich Life Science Cluster Greater Philadelphia's Big Pharmas A Robust Support Infrastructure Barbara Schilberg: Champion for the region Bridging the Gap Investment Momentum Building Update Those Resumes Creating Roots Ramping Up Tech Transfer DUSTIN FENSTERMACHER / WONDERFUL MACHINE Long before Brenda Gavin began i

Written byKaren Pallarito
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

A Region Defined

Did You Know?

A Rich Life Science Cluster

Greater Philadelphia's Big Pharmas

A Robust Support Infrastructure

Barbara Schilberg: Champion for the region

Bridging the Gap

Investment Momentum Building

Update Those Resumes

Creating Roots

Ramping Up Tech Transfer

Long before Brenda Gavin began investing in life science companies, she toiled in the trenches of public health. Fresh out of veterinary school, the Missouri native landed a two-year assignment with the Centers for Disease Control and Prevention's Epidemic Intelligence Service (EIS), a team of doctors, researchers, and scientists who investigate epidemics across the United States and around the globe.

Gavin's team was passionate about its work and kept long hours. Once when a task force was dispatched to Kingsport, Tenn., to investigate an outbreak of Legionnaires' disease in 1977, she and her colleagues continued sifting through medical records even as hospital employees finished their shifts and headed home. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies